Muthanna Medical Journal

作者须在投稿时披露在稿件撰写过程中使用生成式人工智能的情况；该规定仅适用于写作过程，不涵盖用于数据分析或研究见解的AI工具；生成式AI及AI辅助技术仅可用于提升稿件的表达清晰度、可读性和语言水平，且必须在人类监督下使用；作者须负责全面审阅并编辑所有AI生成的内容，因为此类输出可能看似权威却含有不准确之处或遗漏。 模型中文摘要

Authors are required to disclose any use of generative AI in the preparation of their manuscript at the time of submission. This guidance applies exclusively to the writing process and does not cover the use of AI tools for data analysis or research insights. Generative AI and AI-assisted technologies may only be employed to enhance the clarity, readability, and language of the manuscript. These t…

鼓励作者在稿件中说明每位作者对研究和稿件撰写工作的具体贡献。 模型中文摘要

Authors are encouraged to include a statement that specifies the contribution of every author to the research and preparation of the manuscript. Example statement: “All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by [full name], [full name] and [full name]. The first draft of the manuscript was written by [full name] and…

所有作者必须披露潜在的利益冲突；如无利益冲突，应注明“作者声明无利益冲突”。 模型中文摘要

All authors must disclose potential conflicts of interest. If none exist, include: “The authors declare no conflicts of interest.”

作者须提供数据可用性声明，说明支持数据可在何处获取：公共存储库、应请求提供或不适用。 模型中文摘要

Include a Data Availability Statement specifying where supporting data can be accessed: public repository, upon request, or not applicable.

作者须提供伦理审查委员会（IRB）或伦理委员会的批准详情，确认获得知情同意，人体研究须遵循《赫尔辛基宣言》（2013年），动物研究须遵循ARRIVE指南。 模型中文摘要

Provide IRB or Ethics Committee approval details. Confirm informed consent. Follow Declaration of Helsinki (2013) for human studies and ARRIVE for animal studies.

所有文章均采用知识共享署名许可协议（CC BY 4.0）授权，作者保留版权，同时授予MMJ首发权。 模型中文摘要

All articles are licensed under Creative Commons Attribution License (CC BY 4.0). Authors retain copyright while granting MMJ the right of first publication.

所有文章均采用知识共享署名许可协议（CC BY 4.0）授权，作者保留版权，同时授予MMJ首发权。 模型中文摘要

All articles are licensed under Creative Commons Attribution License (CC BY 4.0). Authors retain copyright while granting MMJ the right of first publication.

该期刊采用双盲同行评审，每篇稿件由至少两名审稿人评审；平均时间线为：初审决定2–3周，同行评审4–6周，接受后在线发表。 模型中文摘要

Double-blind peer review. Each manuscript is evaluated by at least two reviewers. Average timeline: Initial decision 2–3 weeks, peer review 4–6 weeks, publication online upon acceptance.

作者须按照公认的报告规范撰写稿件：随机对照试验采用CONSORT，观察性研究采用STROBE，系统综述与荟萃分析采用PRISMA，诊断准确性研究采用STARD，病例报告采用CARE，动物研究采用ARRIVE，定性研究采用SRQR；更多详情可通过EQUATOR Network获取。 模型中文摘要

Authors must prepare manuscripts in accordance with recognized reporting standards: Randomized Controlled Trials: CONSORT Observational Studies: STROBE Systematic Reviews and Meta-Analyses: PRISMA Diagnostic Accuracy Studies: STARD Case Reports: CARE Animal Studies: ARRIVE Qualitative Research: SRQR Further details are available through the EQUATOR Network.